Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combining clinical and molecular data for personalized treatment in acute myeloid leukemia: A machine learning approach.

Computer methods and programs in biomedicine - 1 Dec 2024

Karathanasis Nestoras, Papasavva Panayiota L, Oulas Anastasis, Spyrou George M

Abstract excerpt

BACKGROUND AND OBJECTIVE: The standard of care in Acute Myeloid Leukemia patients has remained essentially unchanged for nearly 40 years. Due to the complicated mutational patterns within and between individual patients and a lack of targeted agents for most mutational events, implementing individualized treatment for AML has proven difficult. We reanalysed the BeatAML dataset employing Machine Learning...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Machine Learning

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 39316958
DOI: 10.1016/j.cmpb.2024.108432

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combining clinical and molecular data for personalized treatment in acute myeloid leukemia: A machine learning approach.PMID 39316958Read ↗

Machine Learning for Predicting Therapeutic Outcomes in Acute Myeloid Leukemia PatientsSemantic proximity Read ↗

Mutation Patterns Predict Drug Sensitivity in Acute Myeloid LeukemiaSemantic proximity Read ↗

Clinical Forecasting using <i>Ex Vivo</i> Drug Sensitivity Profiling of Acute Myeloid LeukemiaSemantic proximity Read ↗

Calibrated Uncertainty Quantification for Patient-Level AML Drug Sensitivity Prediction Using Split Conformal PredictionSemantic proximity Read ↗

Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia.Semantic proximity Read ↗

Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia.Semantic proximity Read ↗

Predicting response to BET inhibitors using computational modeling: A BEAT AML project studySemantic proximity Read ↗

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.Semantic proximity Read ↗

Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.Semantic proximity Read ↗

An Ensemble Model for Acute Myeloid Leukemia Risk Stratification Recommendations by Combining Machine Learning with Clinical GuidelinesSemantic proximity Read ↗

Comparing machine learning models for predicting mutation status in Acute Myeloid Leukemia patients using RNA-seq dataSemantic proximity Read ↗

Utilizing proteomics and phosphoproteomics to predict <i>ex vivo</i> drug sensitivity across genetically diverse AML patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.